Are we entering the era of combination therapy for melanoma?

Melanoma Manag. 2017 Mar;4(1):5-8. doi: 10.2217/mmt-2016-0029. Epub 2017 Mar 1.

Authors

Justine V Cohen¹, Ryan J Sullivan¹

Affiliation

¹ Cancer Center - Massachusetts General Hospital, Boston, MA, USA.

No abstract available

Keywords: BRAF; immunotherapy; targeted therapy.

Publication types

Editorial